Income Statement Isuzu Motors Limited

Equities

7202

JP3137200006

Auto & Truck Manufacturers

Market Closed - Japan Exchange Other stock markets 01:30:00 2025-12-10 am EST			5-day change	1st Jan Change
2,374.00 ^JPY	+0.17%		-0.71%	+9.98%

Nov. 20	Indonesian state-run firm to buy 320,000 vehicles for its cooperative programme, CEO says	RE
Nov. 12	Isuzu Motors' Attributable Profit Drops 11% in Fiscal H1	MT

1750992bc9e7bd3a158.UuhtNFzIc5nDTRqRJGkKQ97qutRY80sGIz9Fxo-F9tU.GpldUzS7K_WpJknLcRBVd6yC_6Ehu3tVV1kEmc3z24UjkAJ2FJkr3YgcLg

Published financial data: ISUZU MOTORS LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	1,908B	2,514B	3,196B	3,387B	3,236B
Total Revenues	1,908B	2,514B	3,196B	3,387B	3,236B
Cost of Goods Sold, Total	1,605B	2,056B	2,600B	2,706B	2,573B
Gross Profit	303B	458B	595B	680B	662B
Selling General & Admin Expenses, Total	192B	245B	315B	355B	430B
Depreciation & Amortization - (IS)	12.22B	21.43B	20.84B	21.99B	-
Other Operating Expenses	3.15B	4.25B	6.23B	10.49B	-1.24B
Other Operating Expenses, Total	207B	271B	342B	387B	429B
Operating Income	95.73B	187B	254B	293B	233B
Interest Expense, Total	-2.86B	-2.13B	-2.23B	-4.18B	-5.75B
Interest And Investment Income	5.46B	8.57B	11.13B	16.01B	18.1B
Net Interest Expenses	2.6B	6.44B	8.9B	11.82B	12.35B
Income (Loss) On Equity Invest.	5.07B	9.62B	5.76B	2.66B	9.17B
Currency Exchange Gains (Loss)	1.75B	5.78B	-2.44B	7.45B	-3.57B
Other Non Operating Income (Expenses)	-590M	-377M	5.05B	-272M	-2.45B
EBT, Excl. Unusual Items	105B	209B	271B	315B	249B
Gain (Loss) On Sale Of Investments	500M	-2.2B	3.04B	-3.75B	-
Gain (Loss) On Sale Of Assets	-795M	-1.44B	-1.15B	905M	-3.2B
Asset Writedown	-14.13B	-592M	-1.21B	-6.3B	-620M
Other Unusual Items	-3.3B	-141M	-1.67B	-3M	-
EBT, Incl. Unusual Items	86.83B	204B	270B	306B	245B
Income Tax Expense	34.29B	47.56B	73.24B	84.24B	64.04B
Earnings From Continuing Operations	52.54B	157B	197B	221B	181B
Net Income to Company	52.54B	157B	197B	221B	181B
Minority Interest	-9.83B	-30.53B	-44.86B	-44.91B	-40.86B
Net Income - (IS)	42.71B	126B	152B	176B	140B
Net Income to Common Incl Extra Items	42.71B	126B	152B	176B	140B
Net Income to Common Excl. Extra Items	42.71B	126B	152B	176B	140B
Per Share Items
Net EPS - Basic	57.91	162.87	195.75	229.92	190.78
Basic EPS - Continuing Operations	57.91	162.87	195.75	229.92	190.78
Basic Weighted Average Shares Outstanding	738M	775M	775M	767M	734M
Net EPS - Diluted	57.91	162.87	195.75	229.92	190.75
Diluted EPS - Continuing Operations	57.91	162.87	195.75	229.92	190.75
Diluted Weighted Average Shares Outstanding	738M	775M	775M	767M	734M
Normalized Basic EPS	75.27	128.91	160.49	197.82	156.14
Normalized Diluted EPS	75.27	128.91	160.49	197.82	156.12
Dividend Per Share	30	66	79	92	92
Payout Ratio	50.14	29.56	37.38	37.87	50.5
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	180B	290B	365B	413B	384B
EBITA	97.94B	192B	258B	298B	233B
EBIT	95.73B	187B	254B	293B	233B
Effective Tax Rate - (Ratio)	39.49	23.28	27.14	27.56	26.14
Normalized Net Income	55.52B	99.88B	124B	152B	115B
Non-Cash Pension Expense	2.97B	1.6B	1.34B	1.29B	23.43B
Supplemental Operating Expense Items
Advertising Expense	14.04B	13.79B	15.59B	20.48B	-
Selling and Marketing Expenses	63.43B	82.19B	110B	107B	-
Research And Development Expense From Footnotes	91B	105B	119B	124B	137B

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	405B	356B	384B	401B	359B
Total Cash And Short Term Investments	405B	356B	384B	401B	359B
Accounts Receivable, Total	423B	561B	596B	641B	661B
Other Receivables	-	-	-	-	7.98B
Total Receivables	423B	561B	596B	641B	668B
Inventory	288B	478B	613B	672B	682B
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	67.8B	96.5B	109B	104B	106B
Total Current Assets	1,183B	1,491B	1,702B	1,818B	1,815B
Net Property Plant And Equipment	768B	919B	936B	976B	947B
Long-term Investments	230B	303B	271B	335B	346B
Goodwill	2.02B	20.52B	18.01B	15.84B	15.21B
Other Intangibles, Total	16.95B	66.89B	56.67B	73.75B	133B
Loans Receivable Long-Term	1.04B	1.04B	1.06B	1.03B	-
Deferred Tax Assets Long-Term	43.85B	55.1B	61.96B	44.27B	45.99B
Other Long-Term Assets, Total	1M	2M	1M	2M	4M
Total Assets	2,245B	2,856B	3,047B	3,263B	3,303B
Liabilities
Accounts Payable, Total	388B	497B	564B	552B	684B
Accrued Expenses, Total	78.42B	125B	143B	171B	-
Short-term Borrowings	52.91B	139B	118B	205B	106B
Current Portion of Long-Term Debt	-	-	-	-	156B
Current Portion of Leases	5.92B	8.66B	7.61B	8.98B	24.44B
Current Income Taxes Payable	17.51B	27.59B	31.26B	32.53B	22.3B
Other Current Liabilities	81.29B	102B	105B	114B	143B
Total Current Liabilities	624B	898B	969B	1,083B	1,136B
Long-Term Debt	243B	367B	365B	319B	382B
Long-Term Leases	14.52B	16.01B	22.61B	23.99B	90.09B
Pension & Other Post Retirement Benefits	89.02B	97.15B	94.42B	86.29B	86.75B
Deferred Tax Liability Non Current	42.72B	46.41B	46.14B	43.54B	10.65B
Other Non Current Liabilities	26.53B	37.3B	39.5B	47.74B	60.41B
Total Liabilities	1,040B	1,462B	1,537B	1,604B	1,766B
Common Stock, Total	40.64B	40.64B	40.64B	40.64B	40.64B
Additional Paid In Capital	42.6B	42.61B	42.05B	43.3B	42.16B
Retained Earnings	850B	928B	1,022B	1,132B	1,162B
Treasury Stock	-54.09B	-3.29B	-3.23B	-53.13B	-2.36B
Comprehensive Income and Other	143B	186B	207B	298B	130B
Total Common Equity	1,022B	1,194B	1,309B	1,461B	1,373B
Minority Interest	183B	200B	202B	198B	165B
Total Equity	1,205B	1,394B	1,510B	1,659B	1,538B
Total Liabilities And Equity	2,245B	2,856B	3,047B	3,263B	3,303B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	777M	775M	775M	749M	712M
ECS Total Common Shares Outstanding	738M	775M	775M	749M	712M
Book Value / Share	1.39K	1.54K	1.69K	1.95K	1.93K
Tangible Book Value	1,003B	1,107B	1,234B	1,371B	1,224B
Tangible Book Value Per Share	1.36K	1.43K	1.59K	1.83K	1.72K
Total Debt	317B	530B	513B	557B	759B
Net Debt	-88.2B	174B	130B	156B	400B
Debt Equivalent of Unfunded Proj. Benefit Obligation	86.64B	94.01B	91.26B	82.51B	73.88B
Minority Interest, Total (Incl. Fin. Div)	183B	200B	202B	198B	165B
Equity Method Investments, Total	-	-	-	-	133B
Inventories - Raw Materials, Total	80.73B	146B	170B	154B	165B
Inventories - Work In Process, Total	25.21B	49.95B	51.29B	72.1B	57.84B
Inventories - Finished Goods, Total	182B	281B	392B	446B	459B
Inventories - Others	-	-	-	-	2M
Full Time Employees	36.22K	44.3K	44.5K	45.03K	42.12K
Accumulated Allowance for Doubtful Accounts (Supple)	1.25B	1.22B	2.37B	2.97B	3.27B

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	86.83B	204B	270B	306B	245B
Depreciation & Amortization - CF	82.35B	98.34B	107B	115B	151B
Amortization of Goodwill and Intangible Assets - (CF)	2.21B	4.33B	4.22B	4.67B	-
Depreciation & Amortization, Total	84.56B	103B	111B	120B	151B
(Gain) Loss From Sale Of Asset	14.64B	1.79B	1.41B	3.69B	3.82B
(Gain) Loss on Sale of Investments - (CF)	-499M	2.2B	-3.04B	-325M	-
(Income) Loss On Equity Investments - (CF)	-5.07B	-9.62B	-5.76B	-2.66B	-9.17B
Other Operating Activities, Total	-28.62B	-44.74B	-68.03B	-66.48B	-93.66B
Change In Accounts Receivable	-11.26B	605M	-8.94B	9.46B	-11.35B
Change In Inventories	38.49B	-105B	-113B	-23.58B	-15.32B
Change In Accounts Payable	24.27B	46.03B	56.79B	-30.14B	-34.24B
Change in Other Net Operating Assets	19.57B	-25.91B	-13.55B	-16.7B	17.81B
Cash from Operations	223B	172B	227B	299B	254B
Capital Expenditure	-97.89B	-100B	-107B	-161B	-159B
Sale of Property, Plant, and Equipment	5.49B	7.31B	6.13B	9.76B	9.24B
Cash Acquisitions	-	-291B	-	-	-469M
Divestitures	-	-	-	-1.76B	-10.98B
Sale (Purchase) of Intangible assets	-	-	-	-	-54.71B
Investment in Marketable and Equity Securities, Total	2B	-36.54B	19.74B	-1.46B	-11.41B
Net (Increase) Decrease in Loans Originated / Sold - Investing	157M	52M	135M	155M	-181M
Other Investing Activities, Total	-3.17B	-802M	789M	-402M	24.98B
Cash from Investing	-93.41B	-421B	-80.53B	-155B	-202B
Short Term Debt Issued, Total	-	41.72B	-	59B	50B
Long-Term Debt Issued, Total	93.3B	226B	117B	92.06B	223B
Total Debt Issued	93.3B	268B	117B	151B	273B
Short Term Debt Repaid, Total	-26.78B	-	-49.4B	-	-3.6B
Long-Term Debt Repaid, Total	-84.87B	-58.14B	-90.58B	-110B	-138B
Total Debt Repaid	-112B	-58.14B	-140B	-110B	-142B
Issuance of Common Stock	-	42.82B	-	-	-
Repurchase of Common Stock	-4M	-2.26B	-38M	-50.01B	-75.6B
Common Dividends Paid	-21.41B	-37.3B	-56.73B	-66.81B	-70.72B
Common & Preferred Stock Dividends Paid	-21.41B	-37.3B	-56.73B	-66.81B	-70.72B
Other Financing Activities, Total	-15.51B	-27.19B	-60.67B	-69.08B	-76B
Cash from Financing	-55.28B	186B	-140B	-145B	-90.6B
Foreign Exchange Rate Adjustments	8.46B	17.71B	18.12B	25.43B	8.37B
Miscellaneous Cash Flow Adjustments	-	2M	-1.62B	-3.46B	1M
Net Change in Cash	82.7B	-44.96B	22.68B	20.48B	-30.52B
Supplemental Items
Cash Interest Paid	2.91B	2.19B	2.21B	4.21B	5.19B
Cash Income Tax Paid (Refund)	30.66B	46.9B	71.97B	74.51B	81.31B
Levered Free Cash Flow	112B	-52.88B	70.25B	67.01B	19.46B
Unlevered Free Cash Flow	114B	-51.55B	71.64B	69.63B	23.05B
Change In Net Working Capital	-67.21B	171B	90.98B	71.88B	60.42B
Net Debt Issued / Repaid	-18.35B	210B	-22.94B	40.92B	132B

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	2.72	4.59	5.37	5.81	4.44
Return on Total Capital	4	6.79	8.03	8.64	6.46
Return On Equity %	4.49	12.06	13.54	13.97	11.32
Return on Common Equity	4.33	11.39	12.13	12.74	9.89
Margin Analysis
Gross Profit Margin %	15.88	18.22	18.63	20.09	20.47
SG&A Margin	10.06	9.76	9.84	10.47	13.3
EBITDA Margin %	9.45	11.53	11.42	12.19	11.88
EBITA Margin %	5.13	7.62	8.07	8.79	7.21
EBIT Margin %	5.02	7.45	7.93	8.65	7.21
Income From Continuing Operations Margin %	2.75	6.23	6.15	6.54	5.59
Net Income Margin %	2.24	5.02	4.75	5.21	4.33
Net Avail. For Common Margin %	2.24	5.02	4.75	5.21	4.33
Normalized Net Income Margin	2.91	3.97	3.89	4.48	3.54
Levered Free Cash Flow Margin	5.87	-2.1	2.2	1.98	0.6
Unlevered Free Cash Flow Margin	5.96	-2.05	2.24	2.06	0.71
Asset Turnover
Asset Turnover	0.87	0.99	1.08	1.07	0.99
Fixed Assets Turnover	2.5	2.98	3.45	3.54	3.37
Receivables Turnover (Average Receivables)	4.62	5.12	5.53	5.47	4.97
Inventory Turnover (Average Inventory)	5.24	5.37	4.77	4.21	3.8
Short Term Liquidity
Current Ratio	1.9	1.66	1.76	1.68	1.6
Quick Ratio	1.33	1.02	1.01	0.96	0.9
Operating Cash Flow to Current Liabilities	0.36	0.19	0.23	0.28	0.22
Days Sales Outstanding (Average Receivables)	78.92	71.36	66.06	66.85	73.41
Days Outstanding Inventory (Average Inventory)	69.59	67.98	76.58	86.9	95.99
Average Days Payable Outstanding	87.19	71.9	70.73	73.86	87.33
Cash Conversion Cycle (Average Days)	61.33	67.45	71.91	79.9	82.08
Long Term Solvency
Total Debt/Equity	26.27	38.04	33.98	33.56	49.35
Total Debt / Total Capital	20.8	27.56	25.36	25.13	33.04
LT Debt/Equity	21.39	27.44	25.67	20.69	30.69
Long-Term Debt / Total Capital	16.94	19.88	19.16	15.49	20.55
Total Liabilities / Total Assets	46.32	51.18	50.43	49.16	53.45
EBIT / Interest Expense	33.49	87.89	113.85	70.03	40.56
EBITDA / Interest Expense	63.06	136.09	163.91	98.64	66.84
(EBITDA - Capex) / Interest Expense	28.82	88.99	115.72	60.07	39.23
Total Debt / EBITDA	1.76	1.83	1.41	1.35	1.97
Net Debt / EBITDA	-0.49	0.6	0.35	0.38	1.04
Total Debt / (EBITDA - Capex)	3.84	2.8	1.99	2.21	3.36
Net Debt / (EBITDA - Capex)	-1.07	0.92	0.5	0.62	1.77
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-8.26	31.77	27.09	5.98	-4.46
Gross Profit, 1 Yr. Growth %	-13.31	51.2	29.9	14.29	-2.64
EBITDA, 1 Yr. Growth %	-17.77	60.77	25.93	13.09	-6.86
EBITA, 1 Yr. Growth %	-31.53	95.56	34.58	15.51	-21.65
EBIT, 1 Yr. Growth %	-31.9	95.54	35.44	15.59	-20.4
Earnings From Cont. Operations, 1 Yr. Growth %	-48.74	198.31	25.45	12.59	-18.27
Net Income, 1 Yr. Growth %	-47.42	195.48	20.25	16.28	-20.62
Normalized Net Income, 1 Yr. Growth %	-24.64	79.91	24.56	22.02	-24.49
Diluted EPS Before Extra, 1 Yr. Growth %	-47.43	181.27	20.19	17.46	-17.04
Accounts Receivable, 1 Yr. Growth %	4.93	32.66	6.34	7.55	3.03
Inventory, 1 Yr. Growth %	-10.98	65.71	28.42	9.5	1.49
Net Property, Plant and Equip., 1 Yr. Growth %	0.74	19.71	1.83	4.28	-2.9
Total Assets, 1 Yr. Growth %	4.32	27.22	6.67	7.1	1.24
Tangible Book Value, 1 Yr. Growth %	7.87	10.36	11.49	11.13	-10.71
Common Equity, 1 Yr. Growth %	7.22	16.86	9.58	11.63	-6.01
Cash From Operations, 1 Yr. Growth %	80.21	-22.82	31.98	31.48	-14.91
Capital Expenditures, 1 Yr. Growth %	-5.39	2.49	6.97	50.38	-1.59
Levered Free Cash Flow, 1 Yr. Growth %	705.86	-147.25	-232.85	-4.61	-70.96
Unlevered Free Cash Flow, 1 Yr. Growth %	626.15	-145.33	-238.98	-2.82	-66.89
Dividend Per Share, 1 Yr. Growth %	-21.05	120	19.7	16.46	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-5.77	9.95	29.41	16.06	0.63
Gross Profit, 2 Yr. CAGR %	-11.15	14.48	40.15	21.84	5.49
EBITDA, 2 Yr. CAGR %	-14.98	14.98	42.29	19.33	2.63
EBITA, 2 Yr. CAGR %	-26.12	15.71	62.23	24.68	-4.87
EBIT, 2 Yr. CAGR %	-26.41	15.39	62.74	25.13	-4.08
Earnings From Cont. Operations, 2 Yr. CAGR %	-38.31	23.66	93.45	18.85	-4.07
Net Income, 2 Yr. CAGR %	-38.64	24.64	88.49	18.25	-3.93
Normalized Net Income, 2 Yr. CAGR %	-23.2	16.44	49.7	23.28	-4.01
Diluted EPS Before Extra, 2 Yr. CAGR %	-37.9	21.6	83.86	18.82	-1.29
Accounts Receivable, 2 Yr. CAGR %	0.67	17.99	18.78	6.94	5.26
Inventory, 2 Yr. CAGR %	-3.18	21.46	45.88	18.59	5.42
Net Property, Plant and Equip., 2 Yr. CAGR %	2.45	9.82	10.41	3.04	0.63
Total Assets, 2 Yr. CAGR %	2.64	15.2	16.5	6.89	4.12
Tangible Book Value, 2 Yr. CAGR %	5.3	9.11	10.92	11.31	-0.39
Common Equity, 2 Yr. CAGR %	4.83	11.94	13.16	10.6	2.43
Cash From Operations, 2 Yr. CAGR %	19.33	17.94	0.93	31.73	5.77
Capital Expenditures, 2 Yr. CAGR %	1.63	-1.53	4.7	26.83	21.65
Levered Free Cash Flow, 2 Yr. CAGR %	37.04	95.13	-20.77	12.57	-47.37
Unlevered Free Cash Flow, 2 Yr. CAGR %	36.59	81.44	-20.62	16.22	-43.28
Dividend Per Share, 2 Yr. CAGR %	-9.96	31.79	62.28	18.07	7.91
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-2.68	5.37	15.39	21.07	8.77
Gross Profit, 3 Yr. CAGR %	-6.41	6.07	19.41	30.93	13.07
EBITDA, 3 Yr. CAGR %	-8.54	5.14	18.52	31.8	9.87
EBITA, 3 Yr. CAGR %	-16.68	2.2	21.69	44.87	6.79
EBIT, 3 Yr. CAGR %	-16.89	1.93	21.72	45.2	7.61
Earnings From Cont. Operations, 3 Yr. CAGR %	-25.5	4.31	24.25	61.51	4.9
Net Income, 3 Yr. CAGR %	-26.06	3.61	23.16	60.46	3.54
Normalized Net Income, 3 Yr. CAGR %	-13.95	2	19.08	39.83	4.7
Diluted EPS Before Extra, 3 Yr. CAGR %	-24.43	2.74	21.13	58.35	5.41
Accounts Receivable, 3 Yr. CAGR %	3.5	10.37	13.97	14.91	5.62
Inventory, 3 Yr. CAGR %	1.45	15.81	23.74	32.58	12.59
Net Property, Plant and Equip., 3 Yr. CAGR %	2.83	7.91	7.09	8.33	1.02
Total Assets, 3 Yr. CAGR %	2.78	10.26	12.29	13.28	4.97
Tangible Book Value, 3 Yr. CAGR %	3.95	6.96	9.89	10.99	3.42
Common Equity, 3 Yr. CAGR %	3.58	8.7	11.15	12.65	4.76
Cash From Operations, 3 Yr. CAGR %	8.03	3.2	22.44	10.23	13.87
Capital Expenditures, 3 Yr. CAGR %	-0.52	1.92	1.23	18.13	16.55
Levered Free Cash Flow, 3 Yr. CAGR %	46.02	-3.9	71.66	-15.72	-28.34
Unlevered Free Cash Flow, 3 Yr. CAGR %	45.21	-5.43	66.01	-15.08	-23.53
Dividend Per Share, 3 Yr. CAGR %	-3.13	21.28	27.63	45.29	11.71
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-0.2	5.18	9.07	9.52	9.24
Gross Profit, 5 Yr. CAGR %	-2.96	6.83	10	12.12	13.63
EBITDA, 5 Yr. CAGR %	-4.84	6.61	9.15	10.6	11.89
EBITA, 5 Yr. CAGR %	-10.7	5.39	8.77	10.66	10.28
EBIT, 5 Yr. CAGR %	-11.01	5.03	8.74	10.64	10.66
Earnings From Cont. Operations, 5 Yr. CAGR %	-17.36	7.69	9.13	9.9	12.04
Net Income, 5 Yr. CAGR %	-17.93	6.1	7.51	9.24	11.51
Normalized Net Income, 5 Yr. CAGR %	-10.19	4.37	7.38	10.03	9.25
Diluted EPS Before Extra, 5 Yr. CAGR %	-16	6.45	7.85	8.89	11.61
Accounts Receivable, 5 Yr. CAGR %	6.18	10.31	9.36	8.99	10.4
Inventory, 5 Yr. CAGR %	2.97	13.29	17.31	16.91	16.06
Net Property, Plant and Equip., 5 Yr. CAGR %	3.56	6.16	5.8	5.93	4.45
Total Assets, 5 Yr. CAGR %	4.41	8.71	8.06	8.9	8.95
Tangible Book Value, 5 Yr. CAGR %	6.41	6.74	6.68	8.68	5.66
Common Equity, 5 Yr. CAGR %	6.34	7.85	7.31	9.46	7.58
Cash From Operations, 5 Yr. CAGR %	10.89	2.6	5.13	13.78	15.48
Capital Expenditures, 5 Yr. CAGR %	-1.63	-0.26	1.54	11.23	8.95
Levered Free Cash Flow, 5 Yr. CAGR %	68.28	9.51	14.34	2.37	6.98
Unlevered Free Cash Flow, 5 Yr. CAGR %	64.18	8.01	14.05	2.7	8.04
Dividend Per Share, 5 Yr. CAGR %	-1.28	15.58	19.08	19.98	19.34